University of Adelaide researchers are playing a leading role in the human trials of Australia’s first needle-free, gene-based COVID-19 vaccine. The extended phase 1 human trial will evaluate a COVID-19 gene-based vaccine called COVIGEN, developed by BioNet and Technovalia. The study is led by Professor Nicholas Wood from the University of Sydney and the Vax4COVID Alliance, which […]